GOLDMAN SACHS GROUP INC - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91790E102. A total of 11 filers reported holding VBI VACCINES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VBI VACCINES INC
ValueSharesWeighting
Q1 2016$86,000
+53.6%
36,440
+58.1%
0.00%
Q4 2015$56,000
-8.2%
23,050
-0.5%
0.00%
Q3 2015$61,000
-24.7%
23,177
-4.2%
0.00%
Q4 2014$81,00024,1860.00%
Other shareholders
VBI VACCINES INC shareholders Q1 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,971,091$12,129,0008.50%
Perceptive Advisors 3,260,356$7,955,0000.59%
Cambridge Investment Research Advisors, Inc. 1,433,100$3,497,0000.08%
TWIN FOCUS CAPITAL PARTNERS, LLC 27,556$67,0000.07%
Sigma Investment Management Co 24,205$59,0000.04%
MORGAN STANLEY 1,470$3,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 18,213$43,0000.00%
BlackRock Fund Advisors 2,024$5,0000.00%
VANGUARD GROUP INC 15,514$37,0000.00%
LSV ASSET MANAGEMENT 4,947$11,0000.00%
View complete list of VBI VACCINES INC shareholders